| Autor: |
Tadashi Namisaki, Norihisa Nishimura, Kenichiro Seki, Yukihisa Fujinaga, Kosuke Kaji, Hitoshi Yoshiji, Akira Mitoro, Masanori Furukawa, Hideto Kawaratani, Takahiro Ozutsumi, Takemi Akahane, Kei Moriya, Koh Kitagawa, Yasuhiko Sawada, Hiroaki Takaya |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Clinical endoscopy. 55(3) |
| ISSN: |
2234-2400 |
| Popis: |
Background/Aims: Covered self-expandable metallic stents (CMSs) are widely used for malignant distal biliary obstructions (MDBOs) caused by pancreatic carcinoma. This study compared the efficacy and safety of the laser-cut-type and braided-type CMSs.Methods: To palliate MDBOs caused by pancreatic carcinoma, the laser-cut-type CMSs was used from April 2014 to March 2017, and the braided-type CMSs was used from April 2017 to March 2019. The tested self-expandable metallic stents were equipped with different anti-migration systems.Results: In total, 47 patients received CMSs for MDBOs (24 laser-cut type, 23 braided-type). The time to recurrent biliary obstruction (TRBO) was significantly longer in the braided-type CMSs (p=0.0008), and the median time to stent dysfunction or patient death was 141 and 265 days in the laser-cut-type CMSs and braided-type CMSs, respectively (p=0.0023). Stent migration was the major cause of stent dysfunction in both groups, which occurred in 37.5% of the laser-cut-type CMSs and 13.0% of the braidedtype CMSs. There were no differences in the survival duration between the groups.Conclusions: The TRBO was significantly longer for the braided-type CMSs with an anti-migration system than for the laser-cuttype. Stent migration tended to be less frequent with the braided-type CMSs than with the laser-cut-type CMSs. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
